Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.
<h4>Background</h4>Data on suppression of HIV replication in the CNS and on the subsequent risk of neurocognitive impairment using monotherapy with boosted protease inhibitors are limited.<h4>Methods</h4>Ours was an exploratory cross-sectional study in patients on lopinavir/r...
Saved in:
| Main Authors: | José R Santos, José A Muñoz-Moreno, José Moltó, Anna Prats, Adrià Curran, Pere Domingo, Josep M Llibre, Daniel R McClernon, Isabel Bravo, Jaume Canet, Victoria Watson, David Back, Bonaventura Clotet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0070201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
by: Ana Pelufo-Pellicer, et al.
Published: (2017-03-01) -
Lopinavir/ritonavir as part of schemes of HAARt in HIV-positive pregnant women and women of reproductive age: the dynamics of clinical and immunological and virological indicators
by: A. B. Konkova-Reidman, et al.
Published: (2015-04-01) -
A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections
by: Purwati, et al.
Published: (2021-01-01) -
Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone
by: Satriyo Dwi Suryantoro, et al.
Published: (2021-09-01) -
Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?
by: Hasan M. Shihab, et al.
Published: (2009-06-01)